A detailed history of Barclays PLC transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Barclays PLC holds 16,032 shares of THRD stock, worth $208,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,032
Previous 26,736 40.04%
Holding current value
$208,416
Previous $294,000 48.3%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$8.6 - $11.24 $92,054 - $120,312
-10,704 Reduced 40.04%
16,032 $152,000
Q4 2023

Feb 15, 2024

BUY
$5.97 - $11.47 $138,659 - $266,402
23,226 Added 661.71%
26,736 $294,000
Q3 2023

Nov 07, 2023

SELL
$4.92 - $7.09 $2,214 - $3,190
-450 Reduced 11.36%
3,510 $23,000
Q2 2023

Aug 03, 2023

SELL
$4.18 - $5.33 $10,508 - $13,399
-2,514 Reduced 38.83%
3,960 $19,000
Q1 2023

May 04, 2023

BUY
$3.95 - $4.49 $12,166 - $13,829
3,080 Added 90.75%
6,474 $27,000
Q4 2022

Feb 13, 2023

SELL
$4.0 - $22.0 $101,424 - $557,832
-25,356 Reduced 88.19%
3,394 $14,000
Q3 2022

Nov 03, 2022

BUY
N/A
28,750 New
28,750 $546,000

Others Institutions Holding THRD

About Third Harmonic Bio, Inc.


  • Ticker THRD
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,328,900
  • Market Cap $524M
More about THRD
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.